Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

Title
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
Authors
Keywords
TNFR2, regulatory T cell, cancer immunotherapy, drug discovery, phenotypic screening
Journal
Oncotarget
Volume 7, Issue 42, Pages -
Publisher
Impact Journals, LLC
Online
2016-09-11
DOI
10.18632/oncotarget.11943

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started